These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31077373)

  • 1. Measurement of CSF α-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.
    García-Ayllón MS; Monge-Argilés JA; Monge-García V; Navarrete F; Cortés-Gómez MA; Sánchez-Payá J; Manzanares J; Gasparini-Berenguer R; Leiva-Santana C; Sáez-Valero J
    J Neurochem; 2019 Jul; 150(2):218-230. PubMed ID: 31077373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.
    Mackin RS; Insel P; Zhang J; Mohlenhoff B; Galasko D; Weiner M; Mattsson N
    J Alzheimers Dis; 2015; 43(3):1007-16. PubMed ID: 25125463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease.
    Toledo JB; Korff A; Shaw LM; Trojanowski JQ; Zhang J
    Acta Neuropathol; 2013 Nov; 126(5):683-97. PubMed ID: 23812319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer's Disease.
    Monge-García V; García-Ayllón MS; Sáez-Valero J; Sánchez-Payá J; Navarrete-Rueda F; Manzanares-Robles J; Gasparini-Berenguer R; Romero-Lorenzo R; Cortés-Gómez MA; Monge-Argilés JA
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577877
    [No Abstract]   [Full Text] [Related]  

  • 6. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
    Wang H; Stewart T; Toledo JB; Ginghina C; Tang L; Atik A; Aro P; Shaw LM; Trojanowski JQ; Galasko DR; Edland S; Jensen PH; Shi M; Zhang J;
    J Alzheimers Dis; 2018; 61(4):1541-1553. PubMed ID: 29376878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.
    Førland MG; Tysnes OB; Aarsland D; Maple-Grødem J; Pedersen KF; Alves G; Lange J
    Eur J Neurol; 2020 Jan; 27(1):43-50. PubMed ID: 31293044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.
    Shi M; Tang L; Toledo JB; Ginghina C; Wang H; Aro P; Jensen PH; Weintraub D; Chen-Plotkin AS; Irwin DJ; Grossman M; McCluskey L; Elman LB; Wolk DA; Lee EB; Shaw LM; Trojanowski JQ; Zhang J
    Alzheimers Dement; 2018 Aug; 14(8):1052-1062. PubMed ID: 29604263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
    Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
    Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies.
    Rossi M; Baiardi S; Teunissen CE; Quadalti C; van de Beek M; Mammana A; Stanzani-Maserati M; Van der Flier WM; Sambati L; Zenesini C; Caughey B; Capellari S; Lemstra AW; Parchi P
    Neurology; 2021 Aug; 97(9):e930-e940. PubMed ID: 34210822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment.
    Korff A; Liu C; Ginghina C; Shi M; Zhang J;
    J Alzheimers Dis; 2013; 36(4):679-88. PubMed ID: 23603399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
    Barba L; Abu Rumeileh S; Bellomo G; Paolini Paoletti F; Halbgebauer S; Oeckl P; Steinacker P; Massa F; Gaetani L; Parnetti L; Otto M
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):83-86. PubMed ID: 35944974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.
    Mattsson N; Insel P; Tosun D; Zhang J; Jack CR; Galasko D; Weiner M;
    PLoS One; 2013; 8(12):e85443. PubMed ID: 24392009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.
    Kapaki E; Paraskevas GP; Emmanouilidou E; Vekrellis K
    PLoS One; 2013; 8(11):e81654. PubMed ID: 24282614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease.
    Majbour NK; Chiasserini D; Vaikath NN; Eusebi P; Tokuda T; van de Berg W; Parnetti L; Calabresi P; El-Agnaf OM
    Sci Rep; 2017 Jan; 7():40263. PubMed ID: 28071698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
    Sanfilippo C; Forlenza O; Zetterberg H; Blennow K
    J Neural Transm (Vienna); 2016 Dec; 123(12):1443-1447. PubMed ID: 27531278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional study of α-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function.
    Tosun D; Hausle Z; Iwaki H; Thropp P; Lamoureux J; Lee EB; MacLeod K; McEvoy S; Nalls M; Perrin RJ; Saykin AJ; Shaw LM; Singleton AB; Lebovitz R; Weiner MW; Blauwendraat C;
    Alzheimers Dement; 2024 Aug; 20(8):5114-5131. PubMed ID: 38770829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice.
    Lilamand M; Clery J; Vrillon A; Mouton-Liger F; Cognat E; Gaubert S; Hourregue C; Martinet M; Dumurgier J; Hugon J; Bouaziz-Amar E; Paquet C
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.